These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21606053)

  • 21. Prognosis of stage pIIIA non small cell lung cancer after mediastinal lymph node dissection or sampling.
    Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A
    J BUON; 2009; 14(1):45-9. PubMed ID: 19373946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial.
    Darling GE; Allen MS; Decker PA; Ballman K; Malthaner RA; Inculet RI; Jones DR; McKenna RJ; Landreneau RJ; Rusch VW; Putnam JB
    J Thorac Cardiovasc Surg; 2011 Mar; 141(3):662-70. PubMed ID: 21335122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival.
    Lee JG; Lee CY; Park IK; Kim DJ; Park SY; Kim KD; Chung KY
    Ann Thorac Surg; 2008 Jan; 85(1):211-5. PubMed ID: 18154813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraoperative staging and surgical management of stage IIIA/N2 non-small cell lung cancer.
    Brichkov I; Keller SM
    Thorac Surg Clin; 2008 Nov; 18(4):381-91. PubMed ID: 19086607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is systemic node dissection for accuracy staging in clinical stage I non-small cell lung cancer worthwhile in the elderly?
    Iwasaki A; Hamatake D; Hamanaka W; Hamada T; Shirakusa T; Yamamoto S; Shiraishi T
    Thorac Cardiovasc Surg; 2008 Feb; 56(1):37-41. PubMed ID: 18200466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of surgical resection of stage IIIa (N2) non small cell lung cancer, according to the site of the mediastinal metastases.
    Maggi G; Casadio C; Cianci R; Molinatti M; Filosso PL; Nicolosi M; Oliaro A
    Int Surg; 1993; 78(3):213-7. PubMed ID: 8276543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis].
    Huang GJ; Fang DK; Cheng GY; Zhang DC
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):62-4. PubMed ID: 16737625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer?
    Doddoli C; Aragon A; Barlesi F; Chetaille B; Robitail S; Giudicelli R; Fuentes P; Thomas P
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):680-5. PubMed ID: 15784374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mediastinal lymph node dissection in left lung cancer].
    Morishita K; Kusajima K; Tanaka H; Kuroki M; Komatsu S
    Kyobu Geka; 1994 Jan; 47(1):24-7. PubMed ID: 8277627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
    Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases].
    Zhang GQ; Han F; Gao SL; A DL; Pang ZL
    Ai Zheng; 2007 May; 26(5):519-23. PubMed ID: 17672944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer.
    Zhong W; Yang X; Bai J; Yang J; Manegold C; Wu Y
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):187-95. PubMed ID: 18457958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is systematic lymph node dissection mandatory or is sampling adequate in patients with stage I non-small-cell lung cancer?
    Mitsos S; Panagiotopoulos N; Patrini D; George RS
    Interact Cardiovasc Thorac Surg; 2019 Apr; 28(4):550-554. PubMed ID: 30496413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thoracoscopic lobectomy with systemic lymph node dissection for lymph node positive non-small cell lung cancer--is thoracoscopic lymph node dissection feasible?
    Shiraishi T; Hiratsuka M; Yoshinaga Y; Yamamoto S; Iwasaki A; Shirakusa T
    Thorac Cardiovasc Surg; 2008 Apr; 56(3):162-6. PubMed ID: 18365976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Relatively non-curative resection for lung cancer: is this a complete resection?].
    Nonaka M; Kadokura M; Yamamoto S; Kataoka D; Iyano K; Kawada T; Takaba T
    Kyobu Geka; 2000 Aug; 53(9):759-62. PubMed ID: 10935403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resectable non-small cell lung cancer: a large-scale retrospective cohort study applying a propensity score.
    Ishiguro F; Matsuo K; Fukui T; Mori S; Hatooka S; Mitsudomi T
    J Thorac Cardiovasc Surg; 2010 Apr; 139(4):1001-6. PubMed ID: 19733863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sampling or node dissection for intraoperative staging of lung cancer: a multicentric cross-sectional study.
    Massard G; Ducrocq X; Kochetkova EA; Porhanov VA; Riquet M
    Eur J Cardiothorac Surg; 2006 Jul; 30(1):164-7. PubMed ID: 16725340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung cancer and its operable brain metastasis: survival rate and staging problems.
    Furák J; Troján I; Szöke T; Agócs L; Csekeö A; Kas J; Svastics E; Eller J; Tiszlavicz L
    Ann Thorac Surg; 2005 Jan; 79(1):241-7; discussion 241-7. PubMed ID: 15620950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Appropriate extent of lymph node dissection for clinical I a stage non-small cell lung cancer].
    Pan TC; Zheng Z; Li J; Chen T; Liu LG; Wei X
    Ai Zheng; 2007 Mar; 26(3):303-6. PubMed ID: 17355796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.